Abstract: Transfusion-acquired babesiosis can be an asymptomatic or self-limited febrile hemolytic illness in a healthy host. A persistent, relapsing and/or fulminant course with the development of life threatening complications may be seen in immunocompromised or splenectomized patients. As in malaria, erythrocyte parasitemia is often associated with non-immune hemolysis, and can be treated with erythrocytapheresis. Just as warm autoantibodies have been reported in malaria infection, the development of autoantibodymediated immune hemolysis has been reported in babesiosis. We treated a previously healthy male with multiple injuries from a motor vehicle accident necessitating massive transfusion. His hospital course was complicated. Late in the hospitalization, his blood smear revealed Babesia microti, confirmed by PCR study and serology. Specific antiobiotic therapy was begun, and severe hemolysis from a high parasite burden required red blood cell exchange which led to rapid abatement of the hemolysis. He had a positive DAT (IgG with a pan-reactive eluate) but no serum autoantibody. This persisted for 10 days following cessation of hemolysis, and became negative while still on antibiotics while his parasite burden became undetectable. Reports of autoimmunity caused by babesiosis often have severe hemolysis from their autoantibodies, but our case shows that immune hemolysis from autoantibodies in babesiosis is not a constant finding. The nature of the autoantigen is unknown.
Introduction
Babesiosis is a zoonotic protozoan disease transmitted primarily by genus Ixodes ticks.
Babesia microti and Babesia divergens are the two most common species of babesia infecting humans in the United States [1] . These parasites can infest erythrocytes and cause malaria-like illness. There has been an increased awareness of transfusion-acquired babesiosis (TAB) in the last two decades, with more than 50 cases reported since 1980 [2] . Several factors contribute to the risk of TAB transmission. Most donor infections are asymptomatic, and currently there is no licensed donor screening assay for Babesia [3] .
Tick borne pathogens can survive in refrigerated [4, 5] or frozen-thawed [6] blood components.
Infections with Babesia can run a varied clinical course. Healthy hosts may have an asymptomatic or self-limited febrile illness. Both adults and children who are immune compromised or have undergone splenectomy are at risk to develop severe symptomatic infections with malaise, myalgias, fever, chills and sweating. These patients may have a chronic persistent, relapsing or fulminant course [1] and develop life threatening complications, including acute respiratory distress syndrome [7] , disseminated intravascular coagulation and acute renal failure [8] . Human babesiosis is often associated with non-immune hemolysis from the erythrocytic parasites, and occasionally thrombocytopenia in more severe cases.
Many infections or inflammatory diseases may cause immune dysregulation; and bacterial, viral and parasitic pathogens have been known to stimulate autoantibodies that crossreact with similar antigens on erythrocytes. Autoimmunity to red blood cells in babesiosis has been documented in humans [9, 10] just as it has been reported in malaria infection [11, 12, 13] . 
Case Report

Discussion
The incubation period for TAB may be longer than after a tick bite [1] , although the delayed onset in our patient may also have been due to the antibiotics he had been on, some of which had partial effectiveness against B. microti. The severity of TAB in our patient can be attributed to his asplenic state, as has been reported, and may have become more clinically apparent as his antibiotic therapies were completed. In a series of cases, Wolf et al, [9] The second report of babesiosis with autoantibodies was described by Evenson, et al, [10] . A 47 year old transplant recipient who had been receiving immunosuppressive therapy for 8 years probably acquired babesia from a tick bite during travel to an endemic area. The patient was treated with antibiotics and red blood cell exchange and stabilized.
Hemolysis improved transiently, but a few weeks after being discharged from the hospital he was readmitted with worsening parasitemia. The DAT was positive for IgG, but not C3. Red blood cell exchange was performed for the second time and his immune suppression therapy was changed. Over the next six weeks he had increasing paresitemia and another two episodes of worsening hemolysis with a positive DAT for both IgG and C3. He was treated with antibiotics and red blood cell and plasma exchanges. Hemolysis appeared to be due primarily to autoantibody rather than parasite burden. When the antibody was no longer detectable parasitemia increased from <1% to 8.2% but he had no worsening of hemolysis. Continued treatment with Clindamycin, Atovaquone and Quinidine alone led to a drop in parasitemia. After two more months no parasites were detected in his red blood cells and the DAT was negative. This patient had persistent parasitemia, and his autoantibody contributed to hemolysis over four months, but disappeared before the eradication of infection.
Our experience underscores that TAB may cause severe hemolysis which can be dramatically improved by exchange erythrocytopheresis.
Our experience also underscores that TAB may cause the development of autoantibodies just as in community acquired babesiosis, but immune hemolysis is not a constant finding and the autoantibody may be transient and clinically innocuous.
